Hsp90 inhibitors suppress HCV replication in replicon cells and humanized liver mice
- 22 December 2006
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 353 (4) , 882-888
- https://doi.org/10.1016/j.bbrc.2006.12.117
Abstract
No abstract availableKeywords
Funding Information
- National Institute of Biomedical Innovation
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 27 references indexed in Scilit:
- Hepatitis C virus replication in mice with chimeric human liversNature Medicine, 2001
- Repopulation of Mouse Liver With Human Hepatocytes And In Vivo Infection With Hepatitis B VirusHepatology, 2001
- Efficacy and Safety of Pegylated (40–Kd) Interferon α–2A Compared With Interferon α–2A in Noncirrhotic Patients With Chronic Hepatitis CHepatology, 2001
- A Dose-Ranging Study of Pegylated Interferon Alfa-2b and Ribavirin in Chronic Hepatitis CHepatology, 2000
- Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell LineScience, 1999
- Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis CNew England Journal of Medicine, 1998
- Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virusHepatology, 1990
- Hepatitis C virus infection is associated with the development of hepatocellular carcinoma.Proceedings of the National Academy of Sciences, 1990
- Detection of Antibody to Hepatitis C Virus in Prospectively Followed Transfusion Recipients with Acute and Chronic Non-A, Non-B HepatitisNew England Journal of Medicine, 1989
- Isolation of a cDNA cLone Derived from a Blood-Borne Non-A, Non-B Viral Hepatitis GenomeScience, 1989